• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG CARD; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG CARD; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 Back to Search Results
Catalog Number 195-000
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Burning Sensation (2146); Skin Inflammation/ Irritation (4545)
Event Date 12/30/2020
Event Type  Injury  
Manufacturer Narrative
Customer was provided instruction/training for the correct procedure as well as the safety data sheets for the kit.No additional information, evaluation or clarification of data is applicable.The reported event is anticipated in nature and severity for binaxnow covid-19 ag card and captured within the product's risk management file.No additional action is necessary.
 
Event Description
The patient reported that the swab used to collect nasal samples on (b)(6) 2020 from both nostrils contained binaxnow covid-19 ag extraction reagent solution.The customer reported experiencing subsequent irritation in both nasal cavities up to the eye and irritation in the throat.The customer reported an exam by a physician who recommended a standard nasal saline spray to be swabbed in the nasal cavity.On (b)(6) 2020, the customer reported an irritation in the right eye and light inflammation in the left nasal cavity.On (b)(6) 2021, the patient reported that she was fine now, and the inflammation in her nostril has reduced.The customer reported that she does not have any further appointment with the doctor at the moment.The patient confirmed no death or serious injury, and she did not experience any delays/impact to treatment.The extraction reagent packaged in this kit contains saline, detergents and preservatives that will inactivate cells and virus particles.Samples eluted in this solution are not suitable for culture.Due to the ingredients of the reagent and the sensitive nature of the nose, there is moderate risk of serious injury to the nose.Therefore, the incident shall be considered reportable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG CARD
Type of Device
LATERAL FLOW IMMUNOASSAY IVD OF COVID-19
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer (Section G)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
alonna pitreau
10 southgate road
scarborough, ME 04074
2077305750
MDR Report Key11229995
MDR Text Key230032735
Report Number1221359-2021-00214
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA202537
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial
Report Date 01/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/26/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number195-000
Date Manufacturer Received12/30/2020
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-